Autres langues Waters Corporation Sao Paulo

Actions

WATC34

BRWATCBDR009

Equipement et technologie médicale avancés

Marché Fermé - Sao Paulo 16:26:43 08/06/2026			Varia. 5j.	Varia. 1 janv.
476,58 ^BRL	+11,39%		-.--%	-9,22%

24/08	Waters : les prévisions pour le T4 sont prudentes, la croissance pourrait atteindre près de 10 % en 2027 selon RBC	MT
21/08	Waters Corporation annonce des changements au sein de sa direction	CI

Autres langues

24/08	Qiagen macht Jonathan Pratt zum neuen Konzernchef
24/08	Waters' Q4 Guide Conservative, 2027 Growth Could Reach High Single Digits, RBC Says
21/08	Waters Corporation Announces Executive Changes
11/08	Tranche Update on Waters Corporation's Equity Buyback Plan announced on January 23, 2019.
06/08	Becton Dickinson raises lower end of annual profit forecast on drug delivery devices strength
04/08	Waters Corporation Provides Earnings Guidance for the Third Quarter Ending October 3, 2026 and Full Fiscal Year Ending December 31, 2026
04/08	Waters Corporation Reports Earnings Results for the Second Quarter and Six Months Ended July 04, 2026
04/08	Waters lifts annual forecasts on strong lab-equipment and diagnostics demand
04/08	Waters Fiscal Q2 Adjusted Earnings, Net Revenue Rise: Issues Q3 Guidance
04/08	(WAT) Waters Expects 2026 Revenue Range $6.42B - $6.48B, vs. FactSet Est of $6.44B
04/08	(WAT) Waters Expects Full Year 2026 Adjusted EPS Range $14.45 - $14.65, vs. FactSet Est of $14.52
04/08	(WAT) Waters Corporation Expects Q3 Adjusted EPS Range $3.95 - $4.05
04/08	Earnings Flash (WAT) Waters Corporation Reports Q2 Revenue $1.65B, vs. FactSet Est of $1.62B
04/08	Earnings Flash (WAT) Waters Corporation Posts Q2 Adjusted EPS $3.05 per Share, vs. FactSet Est of $3.01
04/08	(WAT) Waters Corporation Expects Q3 Revenue Range $1.75B - $1.76B
04/08	Waters: Q2 Earnings Snapshot
04/08	Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results
27/07	Waters Corporation Launches Xevo TQ Absolute XR IVD Mass Spectrometer
27/07	Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer
27/07	Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer
09/07	Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says
02/07	Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call
29/06	Waters Corporation(NYSE:WAT) dropped from Russell Midcap Growth Benchmark
29/06	Waters Corporation(NYSE:WAT) dropped from Russell 1000 Value-Defensive Index
29/06	Waters Corporation(NYSE:WAT) dropped from Russell 3000E Growth Benchmark